United Therapeutics Corp (UTHR)
410.82
+8.24
(+2.05%)
USD |
NASDAQ |
Nov 08, 16:00
410.08
-0.74
(-0.18%)
After-Hours: 20:00
United Therapeutics Revenue (TTM): 2.756B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.756B |
| June 30, 2024 | 2.617B |
| March 31, 2024 | 2.498B |
| December 31, 2023 | 2.328B |
| September 30, 2023 | 2.204B |
| June 30, 2023 | 2.111B |
| March 31, 2023 | 1.981B |
| December 31, 2022 | 1.936B |
| September 30, 2022 | 1.86B |
| June 30, 2022 | 1.789B |
| March 31, 2022 | 1.768B |
| December 31, 2021 | 1.686B |
| September 30, 2021 | 1.655B |
| June 30, 2021 | 1.591B |
| March 31, 2021 | 1.506B |
| December 31, 2020 | 1.483B |
| September 30, 2020 | 1.410B |
| June 30, 2020 | 1.431B |
| March 31, 2020 | 1.442B |
| December 31, 2019 | 1.449B |
| September 30, 2019 | 1.519B |
| June 30, 2019 | 1.530B |
| March 31, 2019 | 1.601B |
| December 31, 2018 | 1.628B |
| September 30, 2018 | 1.711B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.744B |
| March 31, 2018 | 1.744B |
| December 31, 2017 | 1.725B |
| September 30, 2017 | 1.670B |
| June 30, 2017 | 1.632B |
| March 31, 2017 | 1.600B |
| December 31, 2016 | 1.599B |
| September 30, 2016 | 1.595B |
| June 30, 2016 | 1.573B |
| March 31, 2016 | 1.507B |
| December 31, 2015 | 1.466B |
| September 30, 2015 | 1.407B |
| June 30, 2015 | 1.351B |
| March 31, 2015 | 1.327B |
| December 31, 2014 | 1.288B |
| September 30, 2014 | 1.231B |
| June 30, 2014 | 1.203B |
| March 31, 2014 | 1.161B |
| December 31, 2013 | 1.117B |
| September 30, 2013 | 1.072B |
| June 30, 2013 | 1.012B |
| March 31, 2013 | 957.00M |
| December 31, 2012 | 916.08M |
| September 30, 2012 | 867.44M |
| June 30, 2012 | 826.71M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.410B
Minimum
Sep 2020
2.756B
Maximum
Sep 2024
1.875B
Average
1.778B
Median
Revenue (TTM) Benchmarks
| Liquidia Corp | 14.84M |
| Pfizer Inc | 59.37B |
| Tonix Pharmaceuticals Holding Corp | 12.46M |
| Ardelyx Inc | 251.85M |
| Cingulate Inc | -- |